These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 34495449)

  • 1. Exploring the Role of Orexinergic Neurons in Parkinson's Disease.
    Kumar S; Behl T; Sehgal A; Singh S; Sharma N; Bhatia S; Al-Harassi A; Abdel-Daim MM; Bungau S
    Neurotox Res; 2021 Dec; 39(6):2141-2153. PubMed ID: 34495449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orexin and Parkinson's disease: A protective neuropeptide with therapeutic potential.
    Liu C; Xue Y; Liu MF; Wang Y; Chen L
    Neurochem Int; 2020 Sep; 138():104754. PubMed ID: 32422324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orexin pathway in Parkinson's disease: a review.
    Alrouji M; Al-Kuraishy HM; Al-Gareeb AI; Zaafar D; Batiha GE
    Mol Biol Rep; 2023 Jul; 50(7):6107-6120. PubMed ID: 37155018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orexinergic neurons are involved in the chemosensory control of breathing during the dark phase in a Parkinson's disease model.
    Oliveira LM; Falquetto B; Moreira TS; Takakura AC
    Exp Neurol; 2018 Nov; 309():107-118. PubMed ID: 30110606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orexinergic System in Neurodegenerative Diseases.
    Wang Q; Cao F; Wu Y
    Front Aging Neurosci; 2021; 13():713201. PubMed ID: 34483883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of orexinergic system in psychiatric and neurodegenerative disorders: A scoping review.
    Al-Kuraishy HM; Abdulhadi MH; Hussien NR; Al-Niemi MS; Rasheed HA; Al-Gareeb AI
    Brain Circ; 2020; 6(2):70-80. PubMed ID: 33033776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orexins, Sleep, and Blood Pressure.
    Sieminski M; Szypenbejl J; Partinen E
    Curr Hypertens Rep; 2018 Jul; 20(9):79. PubMed ID: 29992504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Subthalamic Neurons are Activated by Both Orexin-A and Orexin-B.
    Sheng Q; Xue Y; Wang Y; Chen AQ; Liu C; Liu YH; Chu HY; Chen L
    Neuroscience; 2018 Jan; 369():97-108. PubMed ID: 29138106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orexins role in neurodegenerative diseases: From pathogenesis to treatment.
    Berhe DF; Gebre AK; Assefa BT
    Pharmacol Biochem Behav; 2020 Jul; 194():172929. PubMed ID: 32315694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The orexin/hypocretin system in neuropsychiatric disorders: Relation to signs and symptoms.
    Fronczek R; Schinkelshoek M; Shan L; Lammers GJ
    Handb Clin Neurol; 2021; 180():343-358. PubMed ID: 34225940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the Orexin System on the Hypothalamus-Pituitary-Thyroid Axis.
    Messina A; De Fusco C; Monda V; Esposito M; Moscatelli F; Valenzano A; Carotenuto M; Viggiano E; Chieffi S; De Luca V; Cibelli G; Monda M; Messina G
    Front Neural Circuits; 2016; 10():66. PubMed ID: 27610076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orexin and Sleep Disturbances in Alpha-Synucleinopathies: a Systematic Review.
    Raheel K; See QR; Munday V; Fakhroo B; Ivanenko O; Salvatelli ML; Mutti C; Goadsby PJ; Delogu A; Naismith SL; Holland P; Parrino L; Chaudhuri KR; Rosenzweig I
    Curr Neurol Neurosci Rep; 2024 Sep; 24(9):389-412. PubMed ID: 39031323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the role of Orexin-A neuropeptide in Parkinson's disease: A systematic review and meta-analysis.
    Suresh V; Bardhan M; Ghosh S; Chandani Y; Satapathy P; Roy P; Shamim MA; Gandhi AP; Sandeep M; Rustagi S; Sah R; Padhi BK
    Clin Neurol Neurosurg; 2024 Jul; 242():108320. PubMed ID: 38781804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurophysiological and Behavioral Effects of Anti-Orexinergic Treatments in a Mouse Model of Huntington's Disease.
    Cabanas M; Pistono C; Puygrenier L; Rakesh D; Jeantet Y; Garret M; Cho YH
    Neurotherapeutics; 2019 Jul; 16(3):784-796. PubMed ID: 30915710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of the orexinergic system in different animal species.
    Azeez IA; Igado OO; Olopade JO
    Metab Brain Dis; 2021 Oct; 36(7):1419-1444. PubMed ID: 34224065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased plasma orexin-A concentrations are associated with the non-motor symptoms in Parkinson's disease patients.
    Huang S; Zhao Z; Ma J; Hu S; Li L; Wang Z; Sun W; Shi X; Li M; Zheng J
    Neurosci Lett; 2021 Jan; 741():135480. PubMed ID: 33161104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orexin-A increases the activity of globus pallidus neurons in both normal and parkinsonian rats.
    Xue Y; Yang YT; Liu HY; Chen WF; Chen AQ; Sheng Q; Chen XY; Wang Y; Chen H; Liu HX; Pang YY; Chen L
    Eur J Neurosci; 2016 Sep; 44(5):2247-57. PubMed ID: 27336845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A physiologically based model of orexinergic stabilization of sleep and wake.
    Fulcher BD; Phillips AJ; Postnova S; Robinson PA
    PLoS One; 2014; 9(3):e91982. PubMed ID: 24651580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Sociability and Social Memory Impairment in the A53T Mouse Model of Parkinson's Disease Are Ameliorated by Chemogenetic Modulation of Orexin Neuron Activity.
    Stanojlovic M; Pallais Yllescas JP; Vijayakumar A; Kotz C
    Mol Neurobiol; 2019 Dec; 56(12):8435-8450. PubMed ID: 31250383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Orexin: clinical and therapeutic implications].
    Mediavilla C; Risco S
    Rev Neurol; 2014 Feb; 58(3):117-24. PubMed ID: 24469938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.